These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 33998086

  • 1. 2010 versus the 2000 consensus criteria in patients with normalised insulin-like growth factor 1 after transsphenoidal surgery has high predictive values for long-term recurrence-free survival in acromegaly.
    Shen M, Chen Z, Shou X, He W, Qiao N, Ma Z, Ye Z, Zhang Y, Zhang Q, Zhou X, Cao X, Zhang Z, Ye H, Li Y, Zhao Y, Li S, He M, Wang Y.
    J Neuroendocrinol; 2021 May; 33(5):e12958. PubMed ID: 33998086
    [Abstract] [Full Text] [Related]

  • 2. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly.
    Wang YY, Waqar M, Abou-Zeid A, Kearney T, Caputo C, Davis J, Trainer P, Higham C, Roncaroli F, Gnanalingham KK.
    Neuroendocrinology; 2022 May; 112(4):345-357. PubMed ID: 34052822
    [Abstract] [Full Text] [Related]

  • 3. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M.
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [Abstract] [Full Text] [Related]

  • 4. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 5. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
    Wang YY, Higham C, Kearney T, Davis JR, Trainer P, Gnanalingham KK.
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C, Oearsakul T.
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [Abstract] [Full Text] [Related]

  • 7. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
    Kristof RA, Grote A, Redel L, Neuloh G, Klingmüller D, Schramm J.
    Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [Abstract] [Full Text] [Related]

  • 10. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH, Oh MC, Lee EJ, Kim SH.
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 12. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
    Brzana JA, Yedinak CG, Delashaw JB, Gultelkin HS, Cook D, Fleseriu M.
    Pituitary; 2012 Dec; 15(4):562-70. PubMed ID: 22183781
    [Abstract] [Full Text] [Related]

  • 13. Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission.
    Cunha MLVD, Borba LAB, Boguszewski CL.
    Endocrine; 2020 Apr; 68(1):182-191. PubMed ID: 32078118
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
    Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
    Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
    [Abstract] [Full Text] [Related]

  • 19. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC.
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.